Sumitomo Pharma America Inc - Company Profile
Powered by 
All the sales intelligence you need on Sumitomo Pharma America Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Sumitomo Pharma America Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Sumitomo Pharma America Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Sumitomo Pharma America Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Sumitomo Pharma America Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Tsutomu Nakagawa, Ph.D.
President; Chief Executive Officer; Director Executive BoardDr. Tsutomu Nakagawa has been the Director, President and Chief Executive Officer of the company since 2024. Prior to this, he served as the Chief Strategy Officer of the company. Previously, he served as the Head of Global Corporate Strategy at Sumitomo Pharma Co.
Ron Gimbel
Chief Financial Officer; Director Executive BoardMr. Ron Gimbel has been the Director and Chief Financial Officer of the company since 2023. Prior to this, he served as the Chief Financial Officer of Flagship Labs and Enterprise. Previously, he served as the Executive Director and Vice President of Bristol-Myers Squibb.
Yumi Sato
Chief Development Officer; Director Executive BoardMs. Yumi Sato has been the Director and Chief Development Officer of the company since 2024. Currently, she is the Executive Officer of the Drug Development Division of Sumitomo Pharma.
Tara Soni
Chief Legal Officer Senior ManagementMs. Tara Soni has been the Chief Legal Officer of the company since 2023. Prior to this, she served as the General Counsel at Sumitovant Biopharma. Previously, she served as the Assistant General Counsel to Perseus Telecom.
Jatin Shah, M.D.
Chief Medical Officer - Oncology Senior ManagementMr. Jatin Shah has been the Chief Medical Officer of the company's oncology division since 2024. Prior to this, he served as the Chief Oncology Development Officer of the company. Previously, he served as the Executive Vice President, Chief Medical Officer, and Global Head of Development of Sumitomo Pharma Oncology.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer